162 related articles for article (PubMed ID: 22306545)
1. [Two cases of thiopurine-induced acute pancreatitis in inflammatory bowel disease].
Nishikawa J; Kudo T; Miyazaki T; Mihara H; Ueda A; Ando T; Kajiura S; Fujinami H; Ogawa K; Hosokawa A; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2012 Feb; 109(2):224-30. PubMed ID: 22306545
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
Stobaugh DJ; Deepak P
Ann Pharmacother; 2014 Oct; 48(10):1282-7. PubMed ID: 24982311
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA; Roberts RL; Kennedy MA
Aliment Pharmacol Ther; 2003 Aug; 18(4):395-400. PubMed ID: 12940924
[TBL] [Abstract][Full Text] [Related]
4. Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease?
Ledder OD; Lemberg DA; Ooi CY; Day AS
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):583-6. PubMed ID: 23783022
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA
Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):563-7. PubMed ID: 15317038
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Ledder O; Lemberg DA; Day AS
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
Marion JF
Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219
[No Abstract] [Full Text] [Related]
8. Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.
Simsek M; Meijer B; Ramsoekh D; Bouma G; van der Wouden EJ; den Hartog B; de Vries AC; Hoentjen F; Dijkstra G; de Boer SY; Jansen JM; van der Meulen AE; Beukers R; Brink MA; Steinhauser T; Oldenburg B; Gilissen LP; Naber TH; Verhagen MA; de Boer NKH; Mulder CJJ;
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):568-570. PubMed ID: 29775790
[TBL] [Abstract][Full Text] [Related]
9. Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study.
Wintzell V; Svanström H; Olén O; Melbye M; Ludvigsson JF; Pasternak B
Lancet Child Adolesc Health; 2019 Mar; 3(3):158-165. PubMed ID: 30685366
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.
Gilissen LPL; Tajzai R; Romberg M; Pierik M; Stronkhorst A; Steenhuisen K; Van Bodegraven A; Daniels A; Wong D
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e102-e107. PubMed ID: 33136726
[TBL] [Abstract][Full Text] [Related]
11. Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients.
Gilissen LP; Derijks LJ; Bos LP; Verhoeven HM; Bus PJ; Hooymans PM; Engels LG
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):705-10. PubMed ID: 15201586
[TBL] [Abstract][Full Text] [Related]
12. Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?
Stocco G; Lanzi G; Yue F; Giliani S; Sasaki K; Tommasini A; Pelin M; Martelossi S; Ventura A; Decorti G
Curr Drug Metab; 2015; 17(1):91-8. PubMed ID: 26526832
[TBL] [Abstract][Full Text] [Related]
13. Optimizing thiopurine therapy in inflammatory bowel disease.
Chevaux JB; Peyrin-Biroulet L; Sparrow MP
Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease.
Wong DR; Coenen MJ; Derijks LJ; Vermeulen SH; van Marrewijk CJ; Klungel OH; Scheffer H; Franke B; Guchelaar HJ; de Jong DJ; Engels LG; Verbeek AL; Hooymans PM;
Aliment Pharmacol Ther; 2017 Feb; 45(3):391-402. PubMed ID: 27943397
[TBL] [Abstract][Full Text] [Related]
15. Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease.
Subramaniam K; Pavli P
J Gastroenterol Hepatol; 2012 Feb; 27(2):193-4. PubMed ID: 22260282
[No Abstract] [Full Text] [Related]
16. [Frequency of serious adverse events of thiopurine treatment in normal thiopurine S-methyltransferase genotype children with inflammatory bowel disease].
Tárnok A
Orv Hetil; 2019 Feb; 160(5):179-185. PubMed ID: 30686035
[TBL] [Abstract][Full Text] [Related]
17. Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry.
Calafat M; Mañosa M; Mesonero F; Guardiola J; Mínguez M; Nos P; Vera I; Taxonera C; Iglesias E; Ricart E; Gisbert JP; Calvet X; García-López S; Monfort D; Pérez Calle JL; Riestra S; Gomollón F; Garcia-Planella E; Bermejo F; Hernández V; Martín-Arranz MD; Gutiérrez A; Torres P; Cañete F; Domènech E;
J Crohns Colitis; 2020 Sep; 14(9):1290-1298. PubMed ID: 32201893
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.
Leong RW; Gearry RB; Sparrow MP
Expert Opin Drug Saf; 2008 Sep; 7(5):607-16. PubMed ID: 18759713
[TBL] [Abstract][Full Text] [Related]
19. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A
Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380
[TBL] [Abstract][Full Text] [Related]
20. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
Broekman MMTJ; Coenen MJH; van Marrewijk CJ; Wanten GJA; Wong DR; Verbeek ALM; Klungel OH; Hooymans PM; Guchelaar HJ; Scheffer H; Derijks LJJ; de Jong DJ;
Inflamm Bowel Dis; 2017 Oct; 23(10):1873-1881. PubMed ID: 28644183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
